Pharmaids Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider and approve the Unaudited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pharmaids Pharmaceuticals has informed BSE that its Board of Directors will meet on Tuesday, November 11, 2025. The main item on the agenda is to consider and approve the Unaudited Financial Results (both standalone and consolidated) for the quarter and half year ended September 30, 2025. The company has also notified that the trading window for dealing in its shares will remain closed for designated persons and their immediate relatives until 48 hours after the results are announced. The letter is signed by the Company Secretary and Compliance Officer, Prasanna Subramanya Bhat, and is dated November 6, 2025.
This is a routine regulatory intimation and does not contain any financial numbers or business updates. Shareholders should watch for the actual Q2/H1 FY26 results on or after November 11, 2025, which could influence the stock price depending on the numbers reported.